FALSINI, MATTEO
 Distribuzione geografica
Continente #
NA - Nord America 2.342
EU - Europa 1.182
AS - Asia 927
SA - Sud America 104
Continente sconosciuto - Info sul continente non disponibili 74
AF - Africa 23
OC - Oceania 12
Totale 4.664
Nazione #
US - Stati Uniti d'America 2.299
RU - Federazione Russa 408
IT - Italia 281
SG - Singapore 229
CN - Cina 226
HK - Hong Kong 148
IE - Irlanda 128
VN - Vietnam 127
PL - Polonia 105
SE - Svezia 90
BR - Brasile 79
KR - Corea 58
IN - India 46
FR - Francia 35
DE - Germania 32
GB - Regno Unito 31
CA - Canada 28
FI - Finlandia 24
JO - Giordania 23
ES - Italia 20
JP - Giappone 14
AR - Argentina 12
ID - Indonesia 12
AU - Australia 11
NL - Olanda 11
BD - Bangladesh 10
MX - Messico 10
TR - Turchia 7
IQ - Iraq 6
UA - Ucraina 6
BE - Belgio 4
EG - Egitto 4
EU - Europa 4
PK - Pakistan 4
SN - Senegal 4
CI - Costa d'Avorio 3
MA - Marocco 3
MY - Malesia 3
PE - Perù 3
VE - Venezuela 3
ZA - Sudafrica 3
AZ - Azerbaigian 2
EC - Ecuador 2
JM - Giamaica 2
LB - Libano 2
OM - Oman 2
PY - Paraguay 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
AW - Aruba 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CH - Svizzera 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
KE - Kenya 1
KZ - Kazakistan 1
LT - Lituania 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RO - Romania 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 4.594
Città #
Santa Clara 571
Ashburn 320
Fairfield 149
Chandler 141
Singapore 140
Dublin 128
Hong Kong 128
San Jose 113
Warsaw 105
Houston 74
Woodbridge 74
Seattle 67
Cambridge 62
Beijing 59
Wilmington 58
Seoul 55
Florence 49
Council Bluffs 42
Dong Ket 40
Ann Arbor 36
Milan 32
Los Angeles 30
Mumbai 30
The Dalles 30
Princeton 29
Ho Chi Minh City 25
Altamura 23
Lawrence 23
Clifton 22
Rome 22
New York 21
Shanghai 21
Lauterbourg 20
Hanoi 18
Barcelona 17
Boston 15
Helsinki 15
Buffalo 14
Moscow 14
Munich 14
Dallas 12
Hefei 12
Falls Church 11
Jakarta 11
Medford 11
Tokyo 11
Paris 10
San Diego 10
Gavirate 9
Melbourne 9
Cagliari 8
Guangzhou 8
Kent 8
Boardman 7
Brooklyn 7
Chennai 7
Orem 7
Jacksonville 6
London 6
Naples 6
Redondo Beach 6
Toronto 6
Basingstoke 5
Bologna 5
Chicago 5
Da Nang 5
Parma 5
Phoenix 5
San Francisco 5
Shenzhen 5
Brussels 4
City of London 4
Dakar 4
Jinan 4
Tianjin 4
Abidjan 3
Atlanta 3
Can Tho 3
Curitiba 3
Denver 3
Haiphong 3
Norwalk 3
Pontassieve 3
Pune 3
Querétaro 3
Reggio Emilia 3
Stockholm 3
São Paulo 3
Thái Nguyên 3
Amman 2
Amsterdam 2
Ankara 2
Baku 2
Biên Hòa 2
Brampton 2
Buenos Aires 2
Camerino 2
Casablanca 2
Charlotte 2
Ferrara 2
Totale 3.158
Nome #
The 1,2,4-Triazolo[4,3-a]pyrazin-3-one as a Versatile Scaffold for the Design of Potent Adenosine Human Receptor Antagonists. Structural Investigations to Target the A2A Receptor Subtype 280
Design and synthesis of new adenosine receptor antagonists as neuroprotective agents 262
Structural investigations on coumarins leading to chromeno[4,3-c]pyrazol-4-ones and pyrano[4,3-c]pyrazol-4-ones: New scaffolds for the design of the tumor-associated carbonic anhydrase isoforms IX and XII 237
3-Hydroxy-1H-quinazoline-2,4-dione as a New Scaffold to Develop Potent and Selective Inhibitors of the Tumor-Associated Carbonic Anhydrases IX and XII 233
The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles 229
Imidazo[1,2-a]pyrazin-8-amine core for the design of new adenosine receptor antagonists: Structural exploration to target the A3 and A2A subtypes 218
Design, synthesis, and pharmacological characterization of 2‑(2- furanyl)thiazolo[5,4‑d]pyrimidine-5,7-diamine derivatives: new highly potent A2A adenosine receptor inverse agonists with antinociceptive activity 212
Modifications on the Amino-3,5-dicyanopyridine Core To Obtain Multifaceted Adenosine Receptor Ligands with Antineuropathic Activity 203
Antioxidant-Conjugated 1,2,4-Triazolo[4,3-a]pyrazin-3-one Derivatives: Highly Potent and Selective Human A2A Adenosine Receptor Antagonists Possessing Protective Efficacy in Neuropathic Pain 200
New 8-amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives. Evaluation of different moieties on the 6-aryl ring to obtain potent and selective human A2A adenosine receptor antagonists 191
Development of novel pyridazinone-based adenosine receptor ligands 190
Exploring the 2- and 5-positions of the pyrazolo[4,3-d]pyrimidin-7-amino scaffold to target human A1 and A2A adenosine receptors 189
The aminopyridine-3,5-dicarbonitrile core for the design of new non-nucleoside-like agonists of the human adenosine A2Breceptor 183
Aminopyridine-3,5-carbonitrile core for the design of new adenosine receptor agonists: structural exploration to target the A1 subtype 177
Novel human adenosine receptor antagonists based on the 7-amino-thiazolo[5,4-d]pyrimidine scaffold. Structural investigations at the 2-, 5- and 7-positions to enhance affinity and tune selectivity 175
3-Hydroxy-1H-quinazoline-2,4-dione derivatives as new potent and selective inhibitors of the tumor-associated carbonic anhydrase IX and XII. 175
2-Aryl-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives as new potent adenosine human A2A receptor antagonists 173
Novel 8-amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives as potent human adenosine A 1 and A 2A receptor antagonists. Evaluation of their protective effect against β-amyloid-induced neurotoxicity in SH-SY5Y cells 171
Structural refinement of pyrazolo[4,3-d]pyrimidine derivatives to obtain highly potent and selective antagonists for the human A3 adenosine receptor 167
Identification of novel thiazolo[5,4-d]pyrimidine derivatives as human A1and A2Aadenosine receptor antagonists/inverse agonists 146
Structure-activity relationship studies and pharmacological characterization of N5-heteroarylalkyl-substituted-2-(2-furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine-based derivatives as inverse agonists at human A2Aadenosine receptor 143
New 5-heteroaryl-pyrazolo[4,3-d]pyrimidin-7-amines as dual human adenosine A1 and A2A receptor antagonists. 141
Thiazolo[5,4-d]pyrimidin-7-amino derivatives as dual human adenosine A2A/A1 receptor antagonists. 139
New aminopyridine-3,5-dicarbonitirles as adenosine A2B receptor non-nucleoside agonists. 136
Crystal Structure and Subsequent Ligand Design of a Nonriboside Partial Agonist Bound to the Adenosine A2A Receptor 94
Totale 4.664
Categoria #
all - tutte 13.201
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.201


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022167 0 0 27 4 6 8 7 13 6 17 30 49
2022/2023522 43 90 45 30 36 96 62 44 56 0 15 5
2023/2024219 5 20 23 10 7 53 9 48 10 18 10 6
2024/20251.347 30 151 71 152 440 213 14 86 62 40 53 35
2025/20261.429 175 177 64 130 163 61 175 70 103 101 51 159
2026/2027124 34 25 65 0 0 0 0 0 0 0 0 0
Totale 4.664